Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC

Abstract Unresectable stage III NSCLC is now treated with chemoradiation (CRT) followed by immune checkpoint inhibitors (ICI). Pneumonitis, a common CRT complication, has heightened risk with ICI, potentially causing severe outcomes. Currently, there are no biomarkers to predict pneumonitis risk or...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Lukas Delasos, Mohammadhadi Khorrami, Vidya S. Viswanathan, Khalid Jazieh, Yifu Ding, Pushkar Mutha, Kevin Stephans, Amit Gupta, Nathan A. Pennell, Pradnya D. Patil, Kristin Higgins, Anant Madabhushi
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Nature Portfolio 2024-12-01
סדרה:	npj Precision Oncology
גישה מקוונת:	https://doi.org/10.1038/s41698-024-00790-9
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!